Scholars Central

Research articlePublished 18 May 2009

A Descriptive Study of Nicotine, Alcohol, and Cannabis Use in Urban, Socially Disadvantaged, Predominantly African-American Patients with First-Episode Nonaffective Psychosis

Authors: Tarianna Stewart, Sandra M. Goulding, Makenya Pringle, Michelle L. Esterberg, Michael T. Compton

Clinical Schizophrenia & Related Psychoses

Volume 4 · Issue 1 · Pages 219–225

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Given the importance of substance use comorbidity among individuals with schizophrenia (even firstepisode patients), and because of the dearth of descriptive reports on substance use among first-episode patients in the United States (especially in minority populations), use of nicotine, alcohol, and cannabis is described in a relatively homogeneous sample of first-episode patients. Methods: One hundred and nine hospitalized patients with first-episode nonaffective psychosis in a public-sector setting (age 23.1±4.7 years, 76.1% male, 89.9% African American) were assessed using a structured, standardized method regarding use of nicotine, alcohol, and cannabis, as well as age at first use, age at beginning weekly use, and age at beginning daily use. Results: Substance use was highly prevalent and progressed substantially during adolescence. Most participants had used all three substances (69.7%, 83.7%, and 73.7% for nicotine, alcohol, and cannabis, respectively) prior to onset of psychotic symptoms. Patients with daily nicotine use had fewer years of education (10.6±2.3 compared to 12.6±2.1, p<0.001); those with weekly alcohol use were significantly older (24.1±4.9 compared to 22.2±4.6, p=0.05) and were more likely to be male (56.4% compared to 43.6%, p=0.01); and patients with daily cannabis use had fewer years of education (10.8±2.2 compared to 12.3±2.4, p<0.01). Conclusions: The very high prevalence of comorbid substance use in this sample, which typically began and progressed well before the onset of psychotic symptoms, suggests that all first-episode patients should be evaluated for comorbid substance use disorders, and integrated treatment approaches should be provided.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Schizophrenia & Related Psychoses
  • SubjectMental Health and Psychology
  • BylineArticles whose byline prints “Tarianna Stewart”
  • BylineArticles whose byline prints “Sandra M. Goulding”
  • BylineArticles whose byline prints “Makenya Pringle”
  • BylineArticles whose byline prints “Michelle L. Esterberg”
  • BylineArticles whose byline prints “Michael T. Compton”